Oncology

Biometrics support that adapts to every oncology indication

Oncology trials make up approximately
40% of our portfolio

Intego Clinical delivers biometrics solutions that help sponsors manage complex data, navigate challenging trial designs, and maintain high-quality standards at every stage of oncology product development. With more than a decade of experience in oncology clinical research, our team supports sponsors and CROs in advancing cancer therapies with confidence and clarity.

Oncology trials make up around 40 percent of our portfolio. We provide end-to-end support across all disease stages, trial phases, and data complexities—from preclinical studies to post-marketing analysis.

Oncology Is Complex. We Make the Data Work for You.

Oncology trials generate massive amounts of clinical data over many years. With rising use of precision medicine, immunotherapies, and targeted therapies, oncology trial designs are more ambitious than ever. Yet despite these breakthroughs, the success rate for oncology trials remains low at just 3.4 percent.

Intego Clinical helps clients manage this complexity with responsive, forward-looking biometrics solutions. We bring together expert teams, proven technology, and a mindset focused on efficiency, accuracy, and impact.

What Sets Intego Clinical Apart in Oncology Trials

Deep experience with oncology studies across solid tumors and hematologic malignancies
Full-service biometrics support from preclinical through post-marketing
Compliance with all global regulatory submission standards
Customized solutions for complex designs, large-scale enrollments, and long-duration studies
Flexible engagement models, including both project-based and long-term support
Trusted by global CROs, large pharmaceutical companies, and emerging biotech companies

A Smarter Approach to Oncology Biometrics

Intego Clinical delivers oncology solutions that are:

Streamlined – With scientific and operational alignment from day one
Agile – Built on flexible engagement models to support changing trial needs
Scalable – Backed by a global delivery team across Eastern and Central Europe, Central Florida, and LATAM
Innovative – Powered by technologies that help uncover clinical insights
Adaptive – Designed around your therapeutic focus and development strategy

Oncology Center of Excellence

Intego Clinical’s Oncology Center of Excellence (CoE) supports project teams with ongoing training, technical resources, and strategic insight. Our internal and external learning programs incorporate real oncology datasets, ensuring that every team member builds practical expertise that translates into stronger study outcomes.

Machine Learning and the Future of Oncology Data

Oncology datasets continue to grow in volume and complexity. Our data science team is actively developing machine learning tools and AI models to help sponsors unlock deeper insights, better understand disease progression, and personalize therapeutic strategies. This work supports a new generation of oncology trials that are more precise, data-rich, and impactful.

Your Oncology Trial Deserves the Right Partner

Success in oncology requires a partner that understands the stakes, adapts quickly, and delivers high-quality results without compromise. Intego Clinical is proud to be that partner for oncology sponsors worldwide. With one of the industry’s most stable delivery teams, we ensure continuity and focus from startup to final submission. Our highly trained biometrics team is trusted by sponsors around the world to handle oncology trials of every size and scope.

10+ years

of experience in Oncology

~40%

of our portfolio are Oncology trials